You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
According to Retraction Watch, Nature Communications has retracted a highly criticized article on mentorship.
ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.
In Genome Research this week: unrecognized spread of SARS-CoV-2 in New York last February, assay of cell line responses to drug treatment, and more.
The screen homed in on a number of genes involved in cholesterol biosynthesis that, when lost, make cells more resistant to infection.
The Manhattan-based lab will scale its capacity to process 20,000 tests per day by November and provide results dedicated to the city.
The US National Institutes of Health is urging clinical trial sponsors to add in years of missing data, according to Stat News.
The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.
In PLOS this week: FANCJ mutations linked to increased sensitivity to certain drugs, host genetic factors influence wound microbiomes, and more.
New York University researchers find that more average- and low-achieving men pursue physics, engineering, and computer science majors than higher-scoring women.
The paper, which is not peer-reviewed, said that use of the test as a first-step screening tool would require confirmation of more than 80 percent of its results.
Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.
23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.
The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.
In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.